Filana Therapeutics, Inc. · NASDAQ:FLNA

Filana Therapeutics, Inc. financial statements

Filana Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0000
Cost of revenue936.0K22.0K58.0K69.0K68.0K58.0K
Gross profit-936.0K-22.0K-58.0K-69.0K-68.0K-58.0K
Research and development26.6M69.6M89.4M68.0M24.8M7.29M6.30M2.97M7.62M9.18M
Selling, general and administrative68.8M71.8M16.5M12.0M8.05M
Operating income-95.4M-141.4M-106.0M-80.0M-32.9M-6.45M-4.96M-6.66M-11.9M-15.0M
Depreciation and amortization903.0K952.0K1.08M804.0K310.0K22.0K58.0K69.0K68.0K58.0K
EBITDA-94.5M-140.5M-104.9M-79.2M-32.6M-6.42M-4.90M-6.59M-11.9M-14.9M
Income before tax-91.0M-24.3M-97.2M-76.2M-32.4M-6.33M-4.63M-6.56M-11.9M-14.8M
Income tax00
Net income-91.0M-24.3M-97.2M-76.2M-32.4M-6.33M-4.63M-6.56M-11.9M-14.8M
Earnings per share, basic-1.88-0.53-2.32-1.90-0.82-0.24-0.27-0.61-1.82-2.28
Earnings per share, diluted-1.88-1.46-2.32-1.90-0.82-0.24-0.27-0.61-1.82-2.28

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents95.5M128.6M121.1M201.0M233.4M93.5M23.1M19.8M10.5M16.6M
Short-term investments2.10M
Receivables120.0K947.0K962.0K
Current assets97.7M136.5M129.6M211.2M244.5M94.0M23.3M20.0M10.7M19.1M
Property, plant and equipment20.6M21.0M21.9M22.9M20.6M11.0K47.0K87.0K156.0K232.0K
Total assets118.4M157.5M151.7M234.8M266.8M94.3M23.5M20.1M10.8M19.3M
Accounts payable6.40M7.65M10.6M4.02M7.13M911.0K453.0K294.0K424.0K303.0K
Current liabilities43.8M11.8M14.2M7.06M12.5M1.86M1.39M511.0K1.13M665.0K
Total debt139.0K236.0K293.0K90.0K
Total liabilities44.0M11.8M14.2M7.29M12.9M2.10M1.39M511.0K1.13M665.0K
Shareholders' equity74.4M145.7M137.5M227.5M253.9M92.2M22.1M19.6M9.70M18.6M
Shares outstanding48.3M48.2M42.2M41.7M40.0M35.2M21.8M17.2M6.60M6.59M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-32.3M-116.9M-82.0M-77.5M-30.2M-5.38M-2.51M-4.77M-8.24M-12.2M
Capital spending-581.0K-103.0K-414.0K-2.71M-22.2M0-18.0K00-75.0K
Free cash flow-32.8M-117.0M-82.4M-80.2M-52.4M-5.38M-2.53M-4.77M-8.24M-12.3M
Cash from investing-581.0K-103.0K-414.0K-2.71M-22.2M360.0K-18.0K2.10M-2.17M
Cash from financing-239.0K124.5M2.56M47.8M192.3M75.4M5.81M14.1M-284.0K
Share buybacks-60.0K
Change in cash-33.1M7.44M-79.9M-32.4M139.9M70.4M3.27M9.33M-6.14M-14.7M